SPECIFIC PROPERTIES OF THE DRUG THERAPY FOR STABLE ANGINA IN MEN
https://doi.org/10.15829/1728-8800-2014-2-61-64
Abstract
According to population studies the prevalence of angina increases with age and is about 4–7% in 65–84 years old men. In drug therapy, except direct action of the medicaments on symptoms and complications of the disease, sexual activity must be taken into account due to its impact on life quality and treatment compliance. Beta-adrenoblockers and sartans are common solution for angina with its usual cardiovascular comorbities. The most selective beta-blocker nebivolol and valsartan do not affect and even increase sexual activity, making them a choice for the treatment of angina in men.
About the Authors
R. G. Oganov
State Research Centre for Preventive Medicine. Moscow, Russia
Russian Federation
Russian Federation
G. Ya. Maslennikova
State Research Centre for Preventive Medicine. Moscow, Russia
Russian Federation
Russian Federation
References
1. Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary. Eur Heart J 2006; 27: 1341–81.
2. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disase. The Task Force on the management of stable coronary artery disease of the ESC. Eur Heart J 2013-doi: 10, 1093/ eurheartj/eht 296/.
3. Marzilli M, Merz CNB, Boden WE, et al. Obstructive Coronary Atherosclerosis and Ischemic Heart Disease. An elusive link. JACC 2012; 60 (11): 951–6.
4. Nusbaum MR. Erectile disfunction: prevalence, etiology, and major risk factors. J Am Osteopath Assoc 2002; 102: (12 Supl.4): 1–6.
5. Jia-Yi Dong, Yong-Hong Zhang, Li-Qiang Qin. Erectile disfunction and risk of cardiovascular disease. Meta-analysis of prospective cohort studies. JACC 2011; 58: 1378–85.
6. Arruda-Olson AM, Mahoney DW, Nehra A, et al. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease. JAMA 2002; 287: 719–25.
7. Fox KM, Thadani U, Ma PTS, et al. Sildenafil citrate does not reduce exercise tolerance in man with erectile dysfunction and chronic stable angina. Eur Heart J 2003; 23: 2206–12.
8. Brixius K, Middeke M, Lichtenthal A, et al. Nitric oxide, erectile dysfunction and beta-blocker treatment: benefit of nebivolol versus metoprolol in hypertensive men. Clinical and Experimental Pharmacology and Physiology 2007; 34: 327–31.
9. Cordero A, Bertomen-Martinez V, Mazon P, et al. Erectile disfunction in high risk hypertensive patients treated with beta-blockade agents. Cardiovascular Theraputics 2010; 28: 15–22.
10. Martsevich SY, Tolpigina SN on behalf of working group on the CABRIOLET trial. Comparison of the influence of long-term treatment based on carvediol or bisoprolol on metabolic parameters and erectile function in hypertensive patients with overweight or obesity. Results of the randomized open-label parallel-groups stepped trial CABRIOLET (part 2). Rational Pharmacoter Card 2012; 8 (5): 626–35. Russian (Марцевич С. Ю., Толпыгина С. Н. от имени рабочей группы по проведению исследования КАБРИОЛЕТ. Сравнительное влияние длительной терапии, основанной на карведилоле и бисопрололе на метаболические параметры и эректильную функцию у больных артериальной гипертонией и избыточной массой тела или ожирением: результаты исследования КАБРИОЛЕТ (часть 2). РФК 2012; 8 (5): 626–35.
11. Fogari R, Preti P, Derosa G, et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002; 58 (3): 177–80.
Review
For citations:
Oganov R.G., Maslennikova G.Ya. SPECIFIC PROPERTIES OF THE DRUG THERAPY FOR STABLE ANGINA IN MEN. Cardiovascular Therapy and Prevention. 2014;13(2):61-64. (In Russ.) https://doi.org/10.15829/1728-8800-2014-2-61-64
Views:
527
Email this article 
